Paradigm Biocapital Advisors LP

Position in RVMD — Revolution Medicines, Inc.

CIK 1855655 NEW YORK, NY

Position in RVMD

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$647,267,116

+$118,040,418 QoQ

Shares Held

6,655,703

+0.2% QoQ

Ownership

3.13%

of shares outstanding

% of Portfolio

13.23%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Paradigm Biocapital Advisors LP holds $4,894,261,596 across 35 Biotechnology names. RVMD ranks #2 (13.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ACLX	Arcellx, Inc.	5,774,016	$662,972,517
2	RVMD	Revolution Medicines, Inc. This page	6,655,703	$647,267,116
3	NUVL	Nuvalent, Inc.	5,324,433	$545,488,160
4	PCVX	Vaxcyte, Inc.	4,793,020	$278,522,392
5	EWTX	Edgewise Therapeutics, Inc.	7,365,038	$231,998,697
6	GMAB	Genmab A/S	7,967,836	$213,777,039
7	INSM	INSMED Inc	1,254,488	$205,133,877
8	TARS	Tarsus Pharmaceuticals, Inc.	2,562,154	$179,735,103

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$647,267,116	6,655,703	+0.2%	Shares	Sole	2026-05-15
2025-12-31	$529,226,698	6,644,403	+6.8%	Shares	Sole	2026-02-17
2025-09-30	$290,627,689	6,223,291	+2.1%	Shares	Sole	2025-11-14
2025-06-30	$224,172,175	6,093,291	-1.4%	Shares	Sole	2025-08-14
2025-03-31	$218,458,004	6,178,111	-5.7%	Shares	Sole	2025-05-15
2024-12-31	$286,633,075	6,553,111	+23.3%	Shares	Sole	2025-02-14
2024-09-30	$240,993,936	5,314,089	+1.0%	Shares	Sole	2024-11-14
2024-06-30	$204,105,244	5,259,089	+80.4%	Shares	Sole	2024-08-14
2024-03-31	$93,949,644	2,914,975	—	Shares	Sole	2024-05-15
No filing history on record for this holder in this stock.